Hillstar Bio Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 23

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $66.5M

  • Investors
  • 5

Hillstar Bio General Information

Description

Developer of autoimmune drugs intended to address unmet medical needs. The company's technique selectively targets and depletes pathogenic immune cells while sparing healthy ones, which addresses specific disease mechanisms by eliminating the underlying source and reducing the risks associated with chronic broad immunosuppression, enabling clients to offer the potential for durable relief and immune reset for patients with autoimmune conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6 Tide Street
  • Boston, MA 02210
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 6 Tide Street
  • Boston, MA 02210
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hillstar Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 25-Mar-2025 $66.5M Completed Pre-Clinical Trials
To view Hillstar Bio’s complete valuation and funding history, request access »

Hillstar Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Hillstar Bio’s complete cap table history, request access »

Hillstar Bio Patents

Hillstar Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026170102-A1 Humanized anti-tcrbv9 antibodies Pending 10-Feb-2025

Hillstar Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hillstar Bio Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Droia Ventures Venture Capital Minority
Frazier Healthcare Partners PE/Buyout Minority
Hummingbird Bioscience VC-Backed Company Minority
LifeArc Ventures Venture Capital Minority
Novo Holdings Venture Capital Minority
To view Hillstar Bio’s complete investors history, request access »

Hillstar Bio FAQs

  • When was Hillstar Bio founded?

    Hillstar Bio was founded in 2023.

  • Where is Hillstar Bio headquartered?

    Hillstar Bio is headquartered in Boston, MA.

  • What is the size of Hillstar Bio?

    Hillstar Bio has 23 total employees.

  • What industry is Hillstar Bio in?

    Hillstar Bio’s primary industry is Drug Discovery.

  • Is Hillstar Bio a private or public company?

    Hillstar Bio is a Private company.

  • What is the current valuation of Hillstar Bio?

    The current valuation of Hillstar Bio is .

  • What is Hillstar Bio’s current revenue?

    The current revenue for Hillstar Bio is .

  • How much funding has Hillstar Bio raised over time?

    Hillstar Bio has raised $66.5M.

  • Who are Hillstar Bio’s investors?

    Droia Ventures, Frazier Healthcare Partners, Hummingbird Bioscience, LifeArc Ventures, and Novo Holdings have invested in Hillstar Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process